Refractory hypertension: Attitudes and perspectives;Hypertension resistante au traitement: Attitudes et perspectives

Medecine et Hygiene

Volumn 55, Issue 2146, 1997, Pages 70-72

  Burnier, M ^a   Waeber, B ^a   Brunner, H R ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; AMPHETAMINE DERIVATIVE; ANABOLIC AGENT; ANTIHYPERTENSIVE AGENT; CHLORPROMAZINE; COCAINE; CORTICOSTEROID; CYCLOSPORIN A; ERYTHROPOIETIN; MONOAMINE OXIDASE INHIBITOR; NICOTINE; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

BLOOD PRESSURE MONITORING; HUMAN; HYPERTENSION; PATIENT COMPLIANCE; RISK FACTOR; SHORT SURVEY;

EID: 0031046714     PISSN: 00256749     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (9)

1. Frohlich ED. Classification of resistant hypertension. Hypertension 1988; 11 (Suppl. 11): 11-67-1170.
2. Yakovlevitch M, Black HR. Resistant hypertension in a tertiary care clinic. Arch Int Med 1991; 151: 1786-92.
3. Alderman MH, Budner N, Cohen H, Lamport B, Ooi WI. Prevalence of drug resistant hypertension. Hypertension 1988; 11 (Suppl. 11): 11-71-11-5.
4. Messerli FH, Ventura HO, Amodeo C. Osler's maneuver and pseudohypertension. N Engl J Med 1985; 312: 1548-51.
5. Setaro JF, Black HR. Refractory Hypertension. N Engl J Med 1992; 327: 543-7.
6. Modan M, Almog S, Fuchs Z, Chetrit A, Lusky A, Halkin H. Obesity, glucose intolerance, hyperinsulinemia, and response to antihypertensive drugs. Hypertension 1991; 17: 565-73.
7. Andersson O. Management of hypertension: Clinical and hemodynamic studies with special reference to patients refractory to treatment. Acta Med Scand 1977; 617 (Suppl): 1-62.
8. The HOT study Group. The Hypertension Optimal Treatment Study (the HOT Study). Blood Pressure 1986; 2: 62-8.
9. Waeber B, Roth D. Erste Resultate der HOT-Studie in der Schweiz. Praxis 1995; 84: 1432-4.